Running at full tilt toward an accelerated approval for its hepatitis C combo, AbbVie today says that it has filed ABT-450/ritonavir, ombitasvir (ABT-267), and dasabuvir (ABT-333) with European regulators for genotype 1 patients.

…read more

Source: AbbVie makes a run at early EU OK for hep C cocktail


0 No comments